Maravai Lifesciences Holdings Inc

MRVI

NASDAQ. Currency in USD

25.53 +0.11 ( +0.43% )

Real time prices: September 30

Market Cap.
3.36B
Beta (5Y monthly)
-
Price/Earnings
13.11
EPS (TTM)
1.97
Forward Dividend
0.00 (0.00%)
Ex-Dividend Date
Volume
1.44M
1y Target Est.
58.12
Day's Range
25.30
-
26.26
52 Week's Range
19.83
-
46.43

Historical Summary

Performance
EPS growth
Share Buybacks

About Maravai Lifesciences Holdings Inc

Sector
Healthcare
Industry
Biotechnology
Website
https://www.maravai.com
Exchange
NASDAQ (XNAS)
Shares Outstanding
131.46M
Employees
550
Address
10770 Wateridge Circle, San Diego, CA, United States, 92121
Maravai LifeSciences Holdings, Inc., a life sciences company, provides products to enable the development of drug therapies, diagnostics, novel vaccines, and support research on human diseases in the United States and internationally. The company's products address the key phases of biopharmaceutical development and include nucleic acids for diagnostic and therapeutic applications, antibody-based products to detect impurities during the production of biopharmaceutical products, and products to detect the expression of proteins in tissues of various species. It operates in two segments, Nucleic Acid Production and Biologics Safety Testing. The Nucleic Acid Production segment manufactures and sells products for use in the fields of gene therapy, nucleoside chemistry, oligonucleotide therapy, and molecular diagnostics, including reagents used in the chemical synthesis, modification, labelling, and purification of deoxyribonucleic acid (DNA) and ribonucleic acid (RNA). This segment also offers messenger RNA, oligonucleotides, and oligonucleotide building blocks, as well as plasmid DNA and CleanCap capping technology. The Biologics Safety Testing segment sells analytical products for use in biologic manufacturing process development, including custom product-specific development antibody and assay development services. This segment also provides HCP ELISA kits, other bioprocess impurity and contaminant ELISA kits, ancillary reagents, and custom services. The company serves biopharmaceutical companies, and other biopharmaceutical and life sciences research companies; and academic research institutions and in vitro diagnostics companies. Maravai LifeSciences Holdings, Inc. was incorporated in 2020 and is headquartered in San Diego, California.

Latest news

Why Stabilis Solutions Shares Jumped Over 71%; Here Are 70 Biggest Movers From Yesterday
Why Stabilis Solutions Shares Jumped Over 71%; Here Are 70 Biggest Movers From Yesterday

Gainers Stabilis Solutions, Inc. (NASDAQ: SLNG) shares climbed 71.3% to close at $8.84 after the...
By Benzinga - 1 week ago

TriLink BioTechnologies, Part of Maravai LifeSciences, Expands its mRNA Raw Material Offering with the First GMP-grade Modified Nucleoside-Triphosphate Product
TriLink BioTechnologies, Part of Maravai LifeSciences, Expands its mRNA Raw Material Offering with the First GMP-grade Modified Nucleoside-Triphosphate Product

TriLink now offers GMP-grade N1-Methyl-Pseudouridine-5’-Triphosphate, a critical raw material for mRNA manufacturing, allowing researchers to...
By GlobeNewswire Inc. - 2 weeks ago

Benzinga's Top Ratings Upgrades, Downgrades For August 25, 2022
Benzinga's Top Ratings Upgrades, Downgrades For August 25, 2022

Upgrades According to Goldman Sachs, the prior rating for FREYR Battery (NYSE:FREY) was changed from...
By Benzinga - 5 weeks ago

Do Options Traders Know Something About Maravai LifeSciences (MRVI) Stock We Don't?
Do Options Traders Know Something About Maravai LifeSciences (MRVI) Stock We Don't?

Investors need to pay close attention to Maravai LifeSciences (MRVI) stock based on the movements...
By Zacks Investment Research - 6 weeks ago

Maravai LifeSciences Holdings, Inc. (MRVI) Q2 2022 Earnings Call Transcript
Maravai LifeSciences Holdings, Inc. (MRVI) Q2 2022 Earnings Call Transcript

MRVI earnings call for the period ending June 30, 2022.
By The Motley Fool - 8 weeks ago

3 of the Best Bear Market Buys for August
3 of the Best Bear Market Buys for August

Buying all three of these stocks would give you some great diversification in toys, tech,...
By The Motley Fool - 8 weeks ago

Maravai LifeSciences Holdings, Inc. (MRVI) Q2 Earnings and Revenues Beat Estimates
Maravai LifeSciences Holdings, Inc. (MRVI) Q2 Earnings and Revenues Beat Estimates

Maravai LifeSciences Holdings, Inc. (MRVI) delivered earnings and revenue surprises of 20% and 3.33%, respectively,...
By Zacks Investment Research - 8 weeks ago

CORRECTION: Maravai Lifesciences Reports Second Quarter 2022 Financial Results
CORRECTION: Maravai Lifesciences Reports Second Quarter 2022 Financial Results

SAN DIEGO, Aug. 04, 2022 (GLOBE NEWSWIRE) -- In a release issued under the same...
By GlobeNewswire Inc. - 8 weeks ago